Penlon buy-out highlights alternative exit option for VC (venture capitalists)
This article was originally published in Clinica
Executive Summary
The prolonged slump in stock markets has reduced the incentive for venture capitalists to put their money into promising companies. However, lack of a clear exit opportunity in the form of an initial public offering need not deter the determined investor, as a recent deal involving UK anaesthesia equipment maker Penlon illustrates.